News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,427 Results
Type
Article (2025)
Company Profile (11)
Press Release (63389)
Section
Business (14395)
Career Advice (60)
Deals (2683)
Drug Delivery (11)
Drug Development (6477)
Employer Resources (6)
FDA (1910)
Job Trends (1286)
News (26395)
Policy (2718)
Tag
2027 Pharm Country Standard (1)
Academia (166)
Accelerated approval (5)
Allergies (19)
Alliances (4840)
ALS (10)
Alzheimer's disease (140)
Antibody-drug conjugate (ADC) (48)
Approvals (1975)
Artificial intelligence (48)
Autoimmune disease (7)
Automation (6)
Bankruptcy (6)
Best Places to Work (1209)
Biosimilars (31)
Biotechnology (9)
Bladder cancer (31)
Brain cancer (8)
Breast cancer (81)
Cancer (482)
Cardiovascular disease (31)
Career advice (55)
CAR-T (14)
CDC (1)
Cell therapy (46)
Cervical cancer (3)
Clinical research (5912)
Collaboration (156)
Compensation (10)
COVID-19 (162)
CRISPR (7)
C-suite (43)
Cystic fibrosis (7)
Data (672)
Depression (2)
Diabetes (39)
Diagnostics (697)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (19)
Drug pricing (12)
Drug shortages (1)
Duchenne muscular dystrophy (33)
Earnings (5381)
Editorial (2)
Employer resources (6)
Events (7763)
Executive appointments (55)
FDA (2262)
Frontotemporal dementia (1)
Funding (94)
Gene editing (7)
Generative AI (7)
Gene therapy (34)
GLP-1 (75)
Government (317)
Grass and pollen (1)
Guidances (45)
Healthcare (1476)
HIV (9)
Huntington's disease (1)
IgA nephropathy (3)
Immunology and inflammation (11)
Immuno-oncology (6)
Indications (21)
Infectious disease (201)
Inflammatory bowel disease (13)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (21)
Interviews (4)
IPO (1258)
Job creations (145)
Job search strategy (50)
JPM (2)
Layoffs (7)
Legal (516)
Liver cancer (3)
Longevity (1)
Lung cancer (70)
Lymphoma (41)
Machine learning (4)
Manufacturing (68)
MASH (8)
Medical device (1563)
Medtech (1565)
Mergers & acquisitions (1522)
Metabolic disorders (81)
Multiple sclerosis (14)
Neurodegenerative disease (30)
Neuropsychiatric disorders (3)
Neuroscience (239)
NextGen: Class of 2026 (440)
Non-profit (235)
Obesity (34)
Opinion (11)
Ovarian cancer (8)
Pain (18)
Pancreatic cancer (8)
Parkinson's disease (25)
Partnered (3)
Patents (36)
Patient recruitment (41)
Peanut (7)
People (3802)
Pharmaceutical (3)
Phase 1 (1493)
Phase 2 (2465)
Phase 3 (2326)
Pipeline (563)
Policy (9)
Postmarket research (252)
Preclinical (560)
Press Release (47)
Prostate cancer (25)
Psychedelics (1)
Radiopharmaceuticals (27)
Rare diseases (41)
Real estate (516)
Recruiting (1)
Regulatory (2299)
Reports (14)
Research institute (150)
Resumes & cover letters (9)
RSV (13)
Schizophrenia (22)
Series A (17)
Series B (25)
Sickle cell disease (5)
Spinal muscular atrophy (4)
Sponsored (3)
Startups (189)
Stomach cancer (2)
Supply chain (5)
Tariffs (1)
The Weekly (2)
Vaccines (80)
Venture capital (1)
Weight loss (25)
Women's health (3)
Date
Last 7 days (49)
Last 30 days (160)
Last 365 days (2586)
2026 (220)
2025 (2747)
2024 (3298)
2023 (3380)
2022 (6559)
2021 (7469)
2020 (6620)
2019 (4575)
2018 (3420)
2017 (3155)
2016 (3031)
2015 (3376)
2014 (2469)
2013 (2202)
2012 (2222)
2011 (2175)
2010 (1860)
Location
Africa (81)
Alabama (1)
Alaska (2)
Arizona (9)
Arkansas (2)
Asia (4978)
Australia (1753)
California (707)
Canada (256)
China (111)
Colorado (22)
Connecticut (80)
Delaware (37)
Europe (13711)
Florida (79)
Georgia (70)
Idaho (5)
Illinois (62)
India (18)
Indiana (94)
Iowa (6)
Japan (84)
Kansas (8)
Maine (6)
Maryland (69)
Massachusetts (528)
Michigan (13)
Minnesota (61)
Missouri (17)
Montana (6)
Nevada (8)
New Hampshire (14)
New Jersey (559)
New Mexico (9)
New York (199)
North Carolina (135)
North Dakota (2)
Northern California (419)
Ohio (11)
Oklahoma (1)
Oregon (1)
Pennsylvania (125)
Rhode Island (1)
South America (74)
South Carolina (3)
Southern California (205)
Tennessee (16)
Texas (89)
United States (3069)
Utah (10)
Virginia (9)
Washington D.C. (6)
Washington State (48)
Wisconsin (11)
Wyoming (1)
65,427 Results for "aribio usa inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dexcel Pharma USA Acquires US Rights to Zubsolv®
January 8, 2026
·
1 min read
Press Releases
PharmaEssentia USA Announces Appointment of Jeffrey Williams as Independent Director
December 25, 2025
·
2 min read
Press Releases
IBSA USA Announces FDA Approval of VYBRIQUE™, the First and Only Oral Film to Treat Men with Erectile Dysfunction
February 5, 2026
·
7 min read
Press Releases
Shimadzu Medical Systems USA announces the release of the SC15
November 24, 2025
·
2 min read
Press Releases
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration
May 9, 2025
·
3 min read
Drug Development
First Participants Enrolled in the AriBio USA Phase 3 Registration Trial to Evaluate AR1001 in Early Alzheimer’s Disease
AriBio USA, a clinical-stage biopharmaceutical company, announced the enrollment of their first participants in their Phase 3 trial to evaluate the efficacy of AR1001 in participants with early Alzheimer’s Disease (AD).
January 5, 2023
·
2 min read
Drug Development
AriBio Receives IND Approval from China’s NMPA for POLARIS-AD, a Phase 3 Trial for the Treatment of Early Alzheimer’s Disease
AriBio Co., Ltd. (AriBio) announces approval of the Investigational New Drug (IND) application by the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for the initiation of the Phase 3 Polaris-AD trial in China of AR1001 in early Alzheimer’s Disease (AD) on May 11th, 2024.
May 14, 2024
·
3 min read
BioMidwest
AriBio Co., Ltd. Announces Strategic Collaboration with Kentucky Clinical Trial Laboratory (KCTL) to Expand Alzheimer’s Disease Testing
AriBio Co., Ltd. announces the expansion of testing for Alzheimer’s disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory for the testing of cerebral spinal fluid to accurately and efficiently aid in the diagnosis of Alzheimer’s disease using the Lumipulse® system from FujireBio.
June 21, 2024
·
3 min read
Drug Development
Adaptive Research Announces it has Begun Enrolling Patients in AriBio’s Phase 3 POLARIS-AD Clinical Trial
September 30, 2024
·
3 min read
Press Releases
PharmaEssentia USA Announces Appointment of Dr. Barry Flannelly as Independent Director
November 10, 2025
·
2 min read
1 of 6,543
Next
